ThailandResearch and clinical trials
Ablation reduced dangerous rhythm episodes in Brugada syndrome
In Thailand, a trial was carried out in patients with Brugada syndrome who had an implanted shock device (defibrillator).
Heart and blood vessel diseases
An inherited disease that disturbs the heart's electrical system. Irregular and dangerous heart rhythms can occur. These rhythms can cause fainting; many people have no complaints at all.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
Orphanet has a guideline for emergency doctors for this disease (language: French, German, Italian, Portuguese). See on Orphanet
This page is translated from the Turkish original.
This disease is followed through the “Heart and blood vessel diseases” group.
The heart beats regularly thanks to electrical signals. These signals are carried by tiny channels in the heart cells. In Brugada syndrome, one of these channels does not work well. An irregular, fast rhythm can develop in the lower chambers of the heart. The structure of the heart is usually normal.
Many people have no symptoms at all. Symptoms usually begin in adulthood and are more common in men.
The diagnosis is based on a heart tracing (ECG), which shows a typical pattern. If needed, a medicine test that brings out this pattern is done under a doctor's supervision. The doctor asks about the family history. A genetic test may be done, but in many people no gene is found.
There is no treatment yet that removes the disease. If the risk is high, a pacemaker-like device is placed under the skin of the chest. This device detects a dangerous rhythm and corrects the heartbeat. Some medicines and high fever can disturb the rhythm; the doctor gives guidance about these. People without symptoms are followed regularly. The doctor who follows the disease decides which treatment is suitable.
The disease is usually passed on through dominant inheritance. A single changed gene is enough. For each child of an affected parent, the chance of passing it on is 1 in 2. Sometimes the change appears for the first time in the person. Genetic counselling guides the family.
Source: MedlinePlus Genetics: Brugada syndrome · NORD: Brugada syndrome
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
ThailandResearch and clinical trials
In Thailand, a trial was carried out in patients with Brugada syndrome who had an implanted shock device (defibrillator).
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 3 active interventional studies for this disease. 1 is recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)Not yet recruitingNCT07146880
Non-drug study (device, procedure, care, etc.)RecruitingNCT05643209
Non-drug study (device, procedure, care, etc.)Not yet recruitingNCT07364656
See all studies on ClinicalTrials.gov · Joining clinical trials
TürkiyeResearch and clinical trials
The heart findings of children with Marfan syndrome were studied at Ordu University.
TürkiyeResearch and clinical trials
Hacettepe University measured anxiety in children with inherited rhythm disorders and in their families.
EuropeResearch and clinical trials
Irbesartan was tested in a trial with 57 adults with vascular EDS.
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:130 · ICD-11 BC65.1
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.